NO20054904L - Ikke-vandige enkeltfasebaerere og formuleringer uttrykkende slike baerere - Google Patents
Ikke-vandige enkeltfasebaerere og formuleringer uttrykkende slike baerereInfo
- Publication number
- NO20054904L NO20054904L NO20054904A NO20054904A NO20054904L NO 20054904 L NO20054904 L NO 20054904L NO 20054904 A NO20054904 A NO 20054904A NO 20054904 A NO20054904 A NO 20054904A NO 20054904 L NO20054904 L NO 20054904L
- Authority
- NO
- Norway
- Prior art keywords
- carriers
- drug formulations
- formulations
- vehicles
- aqueous
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Det beskrives materialer og metoder for å tilveiebringe vehikler eller bærere som er brukbare for å tilveiebringe medikamentformuleringer som tar sikte på å bøte på de potensielle mangler ved kjente, ikke-vandige formuleringer. Særlig inkluderer oppfinnelsen ikke-vandige vehikler som er dannet ved bruk av en kombinasjon av polymerer og oppløsningsmidler som resulterer i et vehikkel som er blandbart med vann. De ikke-vandige vehikler letter formuleringen av medikamentformuleringene som er stabile over tid, selv når de lagres ved eller eksponeres til forhøyede temperaturer. Videre tillater de blandbare vehikler ifølge oppfinnelsen fremstilling av medikamentformuleringer som bevirker reduksjon av opptreden av partiell eller fullstendig tilstopning av avleveringsledningene som er inkludert i avleveringsinnretninger som benyttes for å administrere medikamentformuleringene.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45930003P | 2003-03-31 | 2003-03-31 | |
PCT/US2004/009755 WO2004089335A2 (en) | 2003-03-31 | 2004-03-31 | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20054904D0 NO20054904D0 (no) | 2005-10-24 |
NO20054904L true NO20054904L (no) | 2005-12-15 |
Family
ID=33159638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054904A NO20054904L (no) | 2003-03-31 | 2005-10-24 | Ikke-vandige enkeltfasebaerere og formuleringer uttrykkende slike baerere |
Country Status (20)
Country | Link |
---|---|
US (3) | US20050008661A1 (no) |
EP (1) | EP1610765B1 (no) |
JP (1) | JP2006522133A (no) |
KR (1) | KR20060002922A (no) |
CN (1) | CN1767815A (no) |
AR (1) | AR043811A1 (no) |
AT (1) | ATE404175T1 (no) |
AU (2) | AU2004227837A1 (no) |
BR (1) | BRPI0408925A (no) |
CA (1) | CA2520775A1 (no) |
CL (1) | CL2004000698A1 (no) |
DE (1) | DE602004015755D1 (no) |
HK (1) | HK1090834A1 (no) |
MX (1) | MXPA05010602A (no) |
NO (1) | NO20054904L (no) |
NZ (1) | NZ542867A (no) |
RU (1) | RU2005133427A (no) |
TW (1) | TW200505500A (no) |
WO (1) | WO2004089335A2 (no) |
ZA (1) | ZA200508782B (no) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY125870A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
US7258869B1 (en) | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
US7919109B2 (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US7138105B2 (en) * | 2002-02-27 | 2006-11-21 | Pharmain | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
BR0311897A (pt) * | 2002-06-17 | 2005-04-05 | Alza Corp | Sistema de liberação osmótica com mecanismo de potência de impulso de ordem zero inicial compreendendo um agente osmótico disperso no veìculo fluido |
US7731947B2 (en) * | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
JP2006522133A (ja) * | 2003-03-31 | 2006-09-28 | アルザ・コーポレーション | 非水性単一相の媒体、及び、そのような媒体を利用するフォーミュレーション |
MXPA05010604A (es) * | 2003-03-31 | 2005-11-23 | Alza Corp | Sistema de administracion osmotica y metodo para disminuir los tiempos de arranque para sistemas de administracion osmotica. |
AU2004227985B2 (en) | 2003-03-31 | 2009-04-02 | Intarcia Therapeutics, Inc. | Osmotic pump with means for dissipating internal pressure |
CA2820537C (en) | 2003-04-23 | 2015-10-20 | Valeritas, Inc. | Hydraulically actuated pump for fluid administration |
MXPA06002030A (es) * | 2003-10-31 | 2006-05-17 | Alza Corp | Bomba osmotica con tapon de membrana de auto-retencion, de rapido inicio. |
BRPI0416177A (pt) * | 2003-11-06 | 2007-01-09 | Alza Corp | redutor de taxa de embebição modular para uso com bomba osmótica implantável |
WO2005112977A2 (en) * | 2004-04-23 | 2005-12-01 | Pharmain, Ltd. | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
US20050266087A1 (en) * | 2004-05-25 | 2005-12-01 | Gunjan Junnarkar | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
WO2006014425A1 (en) * | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
US7772182B2 (en) * | 2004-08-05 | 2010-08-10 | Alza Corporation | Stable suspension formulations of erythropoietin receptor agonists |
US20060045891A1 (en) * | 2004-08-24 | 2006-03-02 | Lovalenti Phillip M | Density-matched suspension vehicles and pharmaceutical suspensions |
US20060216242A1 (en) * | 2005-02-03 | 2006-09-28 | Rohloff Catherine M | Suspending vehicles and pharmaceutical suspensions for drug dosage forms |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
JP2008528698A (ja) * | 2005-02-03 | 2008-07-31 | インターシア セラピューティクス,インコーポレイティド | 埋め込み可能なインターフェロン含有デバイス |
TW200640483A (en) * | 2005-02-03 | 2006-12-01 | Alza Corp | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
WO2006083950A2 (en) * | 2005-02-03 | 2006-08-10 | Alza Corporation | Method for reducing the level of peroxides in bopcompatible polymer preparations |
US7959938B2 (en) * | 2005-03-15 | 2011-06-14 | Intarcia Therapeutics, Inc. | Polyoxaester suspending vehicles for use with implantable delivery systems |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
KR101872061B1 (ko) | 2005-12-19 | 2018-06-27 | 파마인 코포레이션 | 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이 조성물의 제조 방법 및 그 조성물의 이용 방법 |
CN101460216B (zh) | 2006-03-30 | 2013-06-19 | 瓦莱里塔斯公司 | 多筒式流体递送器械 |
AU2007266475B2 (en) | 2006-05-30 | 2009-12-03 | Intarcia Therapeutics, Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
AU2007284759B2 (en) | 2006-08-09 | 2010-10-28 | Intarcia Therapeutics, Inc. | Osmotic delivery systems and piston assemblies |
JP5018307B2 (ja) | 2006-09-26 | 2012-09-05 | 富士通株式会社 | レジストパターン厚肉化材料、レジストパターンの形成方法、半導体装置及びその製造方法 |
CN105688191A (zh) | 2007-04-23 | 2016-06-22 | 精达制药公司 | 促胰岛素释放肽的混悬制剂及其应用 |
US7960336B2 (en) * | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
US8563527B2 (en) * | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
WO2009033796A1 (en) * | 2007-09-11 | 2009-03-19 | Mondobiotech Laboratories Ag | Use of a peptide as a therapeutic agent |
US20090176892A1 (en) * | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
DK2240155T3 (da) * | 2008-02-13 | 2012-09-17 | Intarcia Therapeutics Inc | Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler |
NZ592113A (en) * | 2008-10-15 | 2012-04-27 | Intarcia Therapeutics Inc | Highly concentrated drug particles, formulations, suspensions and uses thereof |
MX352878B (es) | 2009-09-28 | 2017-12-13 | Intarcia Therapeutics Inc | Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco. |
US20110223208A1 (en) | 2010-03-09 | 2011-09-15 | Beth Hill | Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
US9072668B2 (en) | 2010-03-09 | 2015-07-07 | Janssen Biotech, Inc. | Non-aqueous high concentration reduced viscosity suspension formulations of antibodies |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9956287B2 (en) * | 2013-02-06 | 2018-05-01 | Perosphere Inc. | Stable glucagon formulations |
ES2959451T3 (es) | 2013-09-11 | 2024-02-26 | Eagle Biologics Inc | Formulaciones proteicas líquidas que contienen organofosfatos |
WO2015158823A1 (de) | 2014-04-16 | 2015-10-22 | Veyx-Pharma Gmbh | Veterinärpharmazeutische zusammensetzung und deren verwendung |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
KR102497368B1 (ko) | 2014-10-01 | 2023-02-10 | 이글 바이올로직스 인코포레이티드 | 점도-저하제를 함유하는 폴리삭카라이드 및 핵산 제형 |
CN113598842A (zh) | 2015-06-03 | 2021-11-05 | 因塔西亚制药公司 | 植入物放置和移除系统 |
MX2018014016A (es) | 2016-05-16 | 2019-08-01 | Intarcia Therapeutics Inc | Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos. |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
EP3565580B1 (en) | 2017-01-03 | 2024-03-06 | i2o Therapeutics, Inc. | Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel |
US10646569B2 (en) | 2017-05-16 | 2020-05-12 | Bhami's Research Laboratory, Pvt. Ltd. | High concentration protein formulations with reduced viscosity |
CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
Family Cites Families (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4069251A (en) * | 1969-02-08 | 1978-01-17 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler | Continuous process for the manufacture of methionine |
US3797492A (en) * | 1972-12-27 | 1974-03-19 | Alza Corp | Device for dispensing product with directional guidance member |
US3987790A (en) * | 1975-10-01 | 1976-10-26 | Alza Corporation | Osmotically driven fluid dispenser |
US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US4305927A (en) * | 1979-02-05 | 1981-12-15 | Alza Corporation | Method for the management of intraocular pressure |
US4304767A (en) * | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
US4562024A (en) * | 1982-07-06 | 1985-12-31 | Sterling Drug Inc. | Process for preparing granulate containing poorly compressible medicinally active matter |
US4865845A (en) * | 1986-03-21 | 1989-09-12 | Alza Corporation | Release rate adjustment of osmotic or diffusional delivery devices |
JPS62267326A (ja) * | 1986-05-15 | 1987-11-20 | Sanyo Chem Ind Ltd | ポリエ−テルの精製法 |
JPH0657722B2 (ja) * | 1986-05-27 | 1994-08-03 | 三菱化成株式会社 | 水溶性ポリマ−組成物 |
US4874388A (en) * | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
US5110596A (en) * | 1988-12-13 | 1992-05-05 | Alza Corporation | Delivery system comprising means for delivering agent to livestock |
US5057318A (en) * | 1988-12-13 | 1991-10-15 | Alza Corporation | Delivery system for beneficial agent over a broad range of rates |
US5059423A (en) * | 1988-12-13 | 1991-10-22 | Alza Corporation | Delivery system comprising biocompatible beneficial agent formulation |
US5034229A (en) * | 1988-12-13 | 1991-07-23 | Alza Corporation | Dispenser for increasing feed conversion of hog |
US5219572A (en) * | 1989-03-17 | 1993-06-15 | Pitman-Moore, Inc. | Controlled release delivery device for macromolecular proteins |
US5112614A (en) * | 1989-09-14 | 1992-05-12 | Alza Corporation | Implantable delivery dispenser |
JP3219096B2 (ja) * | 1990-05-10 | 2001-10-15 | ニコメド ファーマ エイエス | n―グリコフロール類及びn―エチレングリコール類を含有する医薬製剤 |
US5234693A (en) * | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
US5234692A (en) * | 1990-07-11 | 1993-08-10 | Alza Corporation | Delivery device with a protective sleeve |
US5151093A (en) * | 1990-10-29 | 1992-09-29 | Alza Corporation | Osmotically driven syringe with programmable agent delivery |
GB9027422D0 (en) * | 1990-12-18 | 1991-02-06 | Scras | Osmotically driven infusion device |
US5137727A (en) * | 1991-06-12 | 1992-08-11 | Alza Corporation | Delivery device providing beneficial agent stability |
US5221698A (en) * | 1991-06-27 | 1993-06-22 | The Regents Of The University Of Michigan | Bioactive composition |
US5288214A (en) * | 1991-09-30 | 1994-02-22 | Toshio Fukuda | Micropump |
DE4137649C2 (de) * | 1991-11-15 | 1997-11-20 | Gerhard Dingler | Bauelement |
US5456679A (en) * | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect |
US5308348A (en) * | 1992-02-18 | 1994-05-03 | Alza Corporation | Delivery devices with pulsatile effect |
US5368588A (en) * | 1993-02-26 | 1994-11-29 | Bettinger; David S. | Parenteral fluid medication reservoir pump |
US5639477A (en) * | 1993-06-23 | 1997-06-17 | Alza Corporation | Ruminal drug delivery device |
DE4403567A1 (de) * | 1994-02-07 | 1995-08-10 | Storz Karl Gmbh & Co | Vorrichtung zur Durchführung endoskopischer Operationen mittels einer intra- und/oder extrakorporalen Hülle |
US5697975A (en) * | 1994-02-09 | 1997-12-16 | The University Of Iowa Research Foundation | Human cerebral cortex neural prosthetic for tinnitus |
NL9401150A (nl) * | 1994-07-12 | 1996-02-01 | Nederland Ptt | Werkwijze voor het aan een ontvangzijde aanbieden van een van een zendzijde afkomstig eerste aantal videosignalen, alsmede systeem, alsmede zender, alsmede netwerk, en alsmede ontvanger. |
ATE232089T1 (de) * | 1994-11-10 | 2003-02-15 | Univ Kentucky Res Found | Implantierbare wiederauffüllbare vorrichtung mit gesteuerter freisetzung zur verabreichung von arzneistoffen unmittelbar an einen inneren teil des körpers |
SE9501189D0 (sv) * | 1995-03-31 | 1995-03-31 | Pharmacia Ab | Protein formulation |
US7833543B2 (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
US6395292B2 (en) * | 1996-02-02 | 2002-05-28 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
US6156331A (en) * | 1996-02-02 | 2000-12-05 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
US6132420A (en) * | 1996-02-02 | 2000-10-17 | Alza Corporation | Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems |
US6261584B1 (en) * | 1996-02-02 | 2001-07-17 | Alza Corporation | Sustained delivery of an active agent using an implantable system |
DK1238657T3 (da) * | 1996-02-02 | 2005-01-17 | Alza Corp | Vedvarende frigivelse af et aktivt middel ved anvendelse af et implanterbart system |
US5976109A (en) * | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body |
CA2231195C (en) * | 1996-07-08 | 2003-01-21 | Edward Mendell Co., Inc. | Sustained release matrix for high-dose insoluble drugs |
US5780431A (en) * | 1996-09-20 | 1998-07-14 | Neurobiological Technologies, Inc. | Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form |
ES2158611T3 (es) * | 1996-12-20 | 2001-09-01 | Alza Corp | Composicion en gel inyectable con efecto retard y procedimiento para la preparacion de dicha composicion. |
ZA981610B (en) * | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
US5874388A (en) * | 1997-04-02 | 1999-02-23 | Dow Corning Corporation | Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant |
MY125870A (en) * | 1997-07-25 | 2006-08-30 | Alza Corp | Osmotic delivery system flow modulator apparatus and method |
JP3703262B2 (ja) * | 1997-08-19 | 2005-10-05 | 三井化学株式会社 | ポリオキシアルキレンポリオール、軟質ポリウレタンフォーム及び非発泡ポリウレタンの製造方法 |
CN100388916C (zh) * | 1997-12-22 | 2008-05-21 | 阿尔扎有限公司 | 用于控释药物传递装置的速率控制膜 |
WO1999033446A1 (en) * | 1997-12-29 | 1999-07-08 | Alza Corporation | Osmotic delivery system with membrane plug retention mechanism |
PT1041974E (pt) * | 1997-12-30 | 2007-01-31 | Alza Corp | Sistema de entrega de agente benéfico como obturador de membrana |
US6241969B1 (en) * | 1998-06-26 | 2001-06-05 | Elan Corporation Plc | Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
US6248112B1 (en) * | 1998-09-30 | 2001-06-19 | C. R. Bard, Inc. | Implant delivery system |
WO2000033866A1 (en) * | 1998-12-04 | 2000-06-15 | Provalis Uk Limited | Pharmaceutical compositions containing insulin |
US7258869B1 (en) * | 1999-02-08 | 2007-08-21 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle |
CA2361424C (en) * | 1999-02-08 | 2009-04-28 | Alza Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US6541021B1 (en) | 1999-03-18 | 2003-04-01 | Durect Corporation | Devices and methods for pain management |
US20030059376A1 (en) * | 1999-06-04 | 2003-03-27 | Libbey Miles A. | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
CZ20021186A3 (cs) * | 1999-10-04 | 2002-11-13 | Chiron Corporation | Farmaceutické prostředky obsahující stabilizovaný kapalný polypeptid |
US6436091B1 (en) * | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
WO2001043528A2 (en) | 1999-12-17 | 2001-06-21 | Durect Corporation | Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide |
ATE306908T1 (de) * | 1999-12-21 | 2005-11-15 | Alza Corp | Ventil für osmotische vorrichtungen |
US6283949B1 (en) * | 1999-12-27 | 2001-09-04 | Advanced Cardiovascular Systems, Inc. | Refillable implantable drug delivery pump |
AU2001900A (en) * | 1999-12-29 | 2001-07-16 | Progen S.R.L. | Biocompatible hydrogel and method of its production |
US6572890B2 (en) | 2000-01-13 | 2003-06-03 | Osmotica Corp. | Osmotic device containing venlafaxine and an anti-psychotic agent |
WO2001058472A2 (en) * | 2000-02-08 | 2001-08-16 | Allergan, Inc. | Botulinum toxin pharmaceutical compositions |
US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
WO2002028366A2 (en) | 2000-10-06 | 2002-04-11 | Durect Corporation | Devices and methods for management of inflammation |
WO2002067895A2 (en) | 2000-11-16 | 2002-09-06 | Durect Corporation | Implant dosage form and use thereof for the delivery of a cholesterol lowering agent |
EP1339449A2 (en) | 2000-11-29 | 2003-09-03 | Durect Corporation | Devices and methods for controlled delivery from a drug delivery device |
US7318931B2 (en) * | 2001-06-21 | 2008-01-15 | Genentech, Inc. | Sustained release formulation |
WO2003004009A1 (en) * | 2001-07-02 | 2003-01-16 | Geneva Pharmaceuticals, Inc. | Pharmaceutical composition |
US7829109B2 (en) * | 2001-11-14 | 2010-11-09 | Durect Corporation | Catheter injectable depot compositions and uses thereof |
CN1703197A (zh) * | 2001-11-14 | 2005-11-30 | 阿尔扎有限公司 | 可注射的长效组合物和其使用 |
GB2386066A (en) * | 2002-02-28 | 2003-09-10 | Norbrook Lab Ltd | Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species |
JP2006512102A (ja) * | 2002-04-11 | 2006-04-13 | メディミューン・ヴァクシンズ・インコーポレーテッド | 噴霧乾燥による生物活性材料の防腐 |
US20040001889A1 (en) * | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
MXPA05001242A (es) * | 2002-07-31 | 2005-06-08 | Alza Corp | Composiciones de deposito inyectable y usos de las mismas. |
RU2355385C2 (ru) * | 2002-11-06 | 2009-05-20 | Алза Корпорейшн | Композиции пролонгированного действия с контролируемым высвобождением |
WO2004056338A2 (en) * | 2002-12-19 | 2004-07-08 | Alza Corporation | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
JP2006522133A (ja) | 2003-03-31 | 2006-09-28 | アルザ・コーポレーション | 非水性単一相の媒体、及び、そのような媒体を利用するフォーミュレーション |
MXPA06002030A (es) * | 2003-10-31 | 2006-05-17 | Alza Corp | Bomba osmotica con tapon de membrana de auto-retencion, de rapido inicio. |
US20050118206A1 (en) | 2003-11-14 | 2005-06-02 | Luk Andrew S. | Surfactant-based gel as an injectable, sustained drug delivery vehicle |
-
2004
- 2004-03-31 JP JP2006509491A patent/JP2006522133A/ja active Pending
- 2004-03-31 RU RU2005133427/15A patent/RU2005133427A/ru not_active Application Discontinuation
- 2004-03-31 DE DE602004015755T patent/DE602004015755D1/de not_active Expired - Lifetime
- 2004-03-31 CL CL200400698A patent/CL2004000698A1/es unknown
- 2004-03-31 EP EP04749544A patent/EP1610765B1/en not_active Expired - Lifetime
- 2004-03-31 US US10/814,826 patent/US20050008661A1/en not_active Abandoned
- 2004-03-31 KR KR1020057018771A patent/KR20060002922A/ko not_active Application Discontinuation
- 2004-03-31 CN CNA2004800088549A patent/CN1767815A/zh active Pending
- 2004-03-31 AU AU2004227837A patent/AU2004227837A1/en not_active Abandoned
- 2004-03-31 AR ARP040101085A patent/AR043811A1/es not_active Application Discontinuation
- 2004-03-31 BR BRPI0408925-1A patent/BRPI0408925A/pt not_active IP Right Cessation
- 2004-03-31 WO PCT/US2004/009755 patent/WO2004089335A2/en active Application Filing
- 2004-03-31 TW TW093108973A patent/TW200505500A/zh unknown
- 2004-03-31 AT AT04749544T patent/ATE404175T1/de not_active IP Right Cessation
- 2004-03-31 CA CA002520775A patent/CA2520775A1/en not_active Abandoned
- 2004-03-31 MX MXPA05010602A patent/MXPA05010602A/es unknown
- 2004-03-31 NZ NZ542867A patent/NZ542867A/en not_active IP Right Cessation
-
2005
- 2005-07-18 US US11/183,477 patent/US8496943B2/en not_active Expired - Fee Related
- 2005-10-24 NO NO20054904A patent/NO20054904L/no not_active Application Discontinuation
- 2005-10-28 ZA ZA200508782A patent/ZA200508782B/xx unknown
-
2006
- 2006-07-04 HK HK06107533.3A patent/HK1090834A1/xx not_active IP Right Cessation
-
2010
- 2010-08-20 AU AU2010212478A patent/AU2010212478B2/en not_active Ceased
-
2013
- 2013-01-31 US US13/756,435 patent/US20130251674A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE602004015755D1 (de) | 2008-09-25 |
TW200505500A (en) | 2005-02-16 |
AR043811A1 (es) | 2005-08-17 |
EP1610765B1 (en) | 2008-08-13 |
AU2010212478B2 (en) | 2011-06-23 |
WO2004089335A2 (en) | 2004-10-21 |
JP2006522133A (ja) | 2006-09-28 |
WO2004089335A3 (en) | 2005-02-10 |
US20050008661A1 (en) | 2005-01-13 |
NZ542867A (en) | 2009-02-28 |
US20130251674A1 (en) | 2013-09-26 |
CA2520775A1 (en) | 2004-10-21 |
EP1610765A2 (en) | 2006-01-04 |
AU2004227837A1 (en) | 2004-10-21 |
ZA200508782B (en) | 2007-02-28 |
CN1767815A (zh) | 2006-05-03 |
US20050276856A1 (en) | 2005-12-15 |
BRPI0408925A (pt) | 2006-04-04 |
ATE404175T1 (de) | 2008-08-15 |
HK1090834A1 (en) | 2007-01-05 |
CL2004000698A1 (es) | 2005-05-20 |
US8496943B2 (en) | 2013-07-30 |
KR20060002922A (ko) | 2006-01-09 |
MXPA05010602A (es) | 2005-11-23 |
RU2005133427A (ru) | 2006-04-27 |
NO20054904D0 (no) | 2005-10-24 |
AU2010212478A1 (en) | 2010-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054904L (no) | Ikke-vandige enkeltfasebaerere og formuleringer uttrykkende slike baerere | |
EP2261236A3 (en) | Composition for proteasome inhibition | |
ATE480223T1 (de) | Kosmetische zusammensetzungen mit blockcopolymeren und entsprechendes system von dauerhaften kosmetikprodukten | |
EP1854451A3 (en) | Cosmetic compositions containing block copolymers and corresponding long-wearing cosmetic product system | |
WO2006107451A3 (en) | Honokiol derivatives for the treatment of proliferative disorders | |
SG130189A1 (en) | Substituted indole-o-glucosides | |
WO2006036994A3 (en) | Modulators of crth2, cox-2 and faah | |
NO20065455L (no) | Topiske metadonsammensetninger og metoder for anvendelse av de samme | |
WO2006083936A3 (en) | Anti-ephb2 antibodies and methods using same | |
WO2005089728A3 (en) | Means for transdermal administration of nicotine | |
WO2004112695A3 (en) | Methods and compositions for delivery of catecholic butanes for treatment of obesity | |
WO2006138099A3 (en) | Bone morphogenetic protein formulations | |
WO2005077365A3 (en) | Novel uses for proton pump inhibitors | |
WO2004093800A3 (en) | Thyronamine derivatives and analogs and methods of use thereof | |
NO20064926L (no) | Fremgangsmater og sammensetninger for harfjerning | |
WO2004091645A3 (en) | Composition comprising rosmarinic acid, borneol and ginsenoside | |
AU2003256203A1 (en) | Alpha-7 nicotinic receptor agonists and statins in combination | |
WO2006131401A3 (en) | Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent | |
WO2005107467A3 (en) | Compositions including opioids and methods of their use in treating pain | |
NO20075140L (no) | Fremgangsmater og preparater for modulering av vaskulaer integritet | |
AU2003286474A1 (en) | Compositions, solutions, and methods used for transplantation | |
ATE475408T1 (de) | Formulierungen von tipifarnib zur intravenösen verabreichung | |
NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner | |
WO2005033113A3 (en) | Indole derivatives | |
WO2002011724A3 (en) | Neuroprotective 2-pyridinamine compositions and related methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |